"Due to unavailability of stock, the BKC COVID vaccination centre will be non-functional temporarily untill further orders," read a poster stock outside the centre.
The government has been monitoring the situation very closely, and based on the strategy adopted for prioritising the groups for vaccination to contain the spread of COVlD-19.
The Ministry said that eight States account for 60 per cent of the cumulative vaccine doses given so far. Maharashtra alone accounts for 9.72 per cent of the total doses given in the country.
83.76 per cent of the new cases are from Maharashtra, Kerala, Punjab, Karnataka, Gujarat and Tamil Nadu.
Iran's Supreme Leader Ayatollah Ali Khamenei has banned imports of the American and Britain vaccines, a reflection of mistrust toward the West.
Wealthy nations have turned towards subsiding their own pharmaceutical companies and locking in vaccine supplies for their population.
Health Minister Zahid Maleque, who inaugurated the campaign, urged people not to spread propaganda against the vaccine, saying it is safe and has no side effects.
In the last 24 hours, 1,88,762 healthcare workers were vaccinated across 3,845 sessions. 76,576 sessions have been conducted so far.
Dr Sagar Rajbhandari, director of Sukraraj Tropical and Infectious Disease Hospital, Teku was the first among the front-line workers to receive the jab, according to Health Ministry sources.
In view of Republic Day celebrations across the country, limited number of sessions in limited States were conducted, the union health ministry said.
All 16 sessions planned for shots conducted across Krishna district, no case of Adverse Events Following Immunisation reported on sixth day in Andhra Pradesh.
A doctor, who worked in the Covid-19 ICU of a private hospital in Chennai for seven months, said that he would not get himself inoculated.
The hospitals where the COVID-19 shots will be administered include AIIMS, Safdarjung, Lok Nayak, GTB, Hindu Rao, Max, Fortis, Apollo, BL Kapur and Sir Gangaram.
The two largest storage facilities are in Bengaluru and Belagavi, followed by five regional spaces in Chitradurga, Kalaburagi, Dakshina Kannada, Mysuru and Bagalkot.
India's drugs regulator had recently approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use